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Summary.-The kinetics of development and subsequent growth of a C3H mouse
mammary tumour after implantation of 106 cells was quantified by observation and
statistical analysis of latent period and growth rate for different categories oftumour.
These comprised control tumours, tumours recurring after large single doses of
X-rays alone and in combination with misonidazole, tumours developing from cells
implanted both outside and within the sites of tumours previously cured by irradia-
tion, tumours developing from cells implanted in heavily irradiated skin, and
tumours developing from cells taken from tumours recurring after irradiation and
re-implanted in untreated skin. The kinetics of development and growth of tumours
in host animals previously treated by i.p. injection of killed tumour cells was also
quantified.
The results confirm that tumour development and growth is significantly perturbed
by irradiation of host tissues both before and after tumour transplantation, and that
this perturbation involves an extended latent period, a slower average rate of growth
and a less uniform pattern of growth. These effects result from localized radiation
damage to host tissues, are not attributable to residual damage to irradiated tumour
cells, and are not markedly dose-dependent within the dose range 25-80 Gy. These
results are consistent with the complete sterilization of host endothelial cells by
doses of25 or more.
In marked contrast to the growth-slowing effect of irradiation, the treatment of
host animals by previous injection of radiation-killed tumour cells led to a reduced
latent period and a faster average rate of growth.
THE MODIFICATION of growth kinetics
which occurs for tumours recurring after
sub-curative therapy with large doses of
radiation has been recognized for many
years (Stenstrom et al., 1955; Summers
et al., 1964; Thomlinson & Craddock,
1967). Despite this widespread recognition,
quantitation ofthese effects in statistically
valid terms remains insufficient, and has
led to disagreement as to whether tumours
do (Suit & Shalek, 1963; Breur, 1966) or
do not resume their former growth rate,
and whether there exist secondary modi-
fications of growth as recurrent tumours
approach their original size (Brown &
Howes, 1974; McNally, 1974).
Such information is essential for any
meaningful attempt to assess levels of
tumour-cell survival by back-extrapola-
tion of growth curves after irradiation
(Hawkes et al., 1968) or cytotoxic drugs
(Berenbaum, 1972; Lloyd, 1975) or by
methods of assay which require this
assumption (Alfieri & Hahn, 1978).
In this study we seek to derive con-
clusions on the perturbation of tumour
growth by X-rays alone and in combina-
tion with misonidazole (MISO). We have
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also examined the possibility that tumour
growth may be perturbed by previous
exposure of host animals to killed tumour
cells, a possibility ofinterest in relation to
immunotherapy.
We have quantitatively examined the
statistical distributions of latent period
and/or growth rate for tumours belonging
to the following experimental categories:
(a) Control tumours, viz. tumours develop-
ing from untreated cells implanted in
untreated hosts;
(b) Tumours recurrent after sub-curative
therapy with large single doses of X-
rays alone and with MISO;
(c) Tumours developing from untreated
cells implanted in heavily irradiated
skin;
(d) Tumours developing from untreated
cells implanted in the sites of tumours
previously cured by X-rays alone or in
combination with MISO;
(e) Tumours developing from untreated
cells implanted just outside the sites of
tumours previously cured by X-rays
alone or in combination with MISO;
(f) Tumours developing from cells taken
from tumours, in other hosts, recurrent
after sub-curative therapy and re-
implanted in untreated skin;
(g) Tumours developing from untreated
cells implanted in hosts previously ex-
posed to killed tumour cells by 3
inoculations, each of 2 x 106 radiation-
sterilized cells in each of 3 preceding
weeks.
MATERIALS AND METHODS
Tumour system.-The multiple-generation
C3H mouse mammary carcinoma is a poorly
differentiated adenocarcinoma of spon-
taneous origin which has been routinely
transplanted every 2-3 wAeeks since 1973 in
syngeneic recipients. The histology, pattern
of growth and gross response to irradiation
are now stable. The rate ofgrowth is very fast
with a volume-doubling time of 1 day at
1-2 mm diameter, lengthening to 3 days at
10-12 mm diameter.
The TCD50 for X-rays is 67 Gy. The
"take rate" for 106 cells implanted in the
dorsal skin ofuntreated mice is close to 1000%.
No spontaneous regressions of wvell-estab-
lished tumours have been recorded.
Tumour transplantation technique.-The
tumour-cell suspension was prepared from a
tumour of 10 mm diameter by gentle mash-
ing, passage through a steel mesh and a
series of needles of decreasing size, counting
the number of cells judged as viable under a
phase-contrast microscope, diluting to 106
cells in 0-05 ml and implantation in the
dorsum.
Irradiation techniques. The X-irradiations
were performed using a Siemens Stabiliplan
machine operating at 250 kV and a filament
current of 15 mA. Beam filtration was such
as to give an experimentally determined first
HVL of 1-85 +0*05 Cu and a dose rate of
1410 Gy/min at 57 cm FSD.
All in vivo irradiations were carried out at
room temperature, with mice breathing air
and without anaesthesia in specially designed
cylindrical jigs made of lead 2 mm thick to
shield all the body of the mouse except the
tumour. Extra lead sheets were used to limit
the width ofthe field of irradiation to 1-5 cm,
across which 4 tumours could be irradiated
simultaneously in a tangential position.
Since the X-ray beam was vertical, the mice
were lying on their sides throughout the
irradiation, a position which they tolerated
well.
For "immunization" studies, a tumour-cell
suspension of 106 cells/0 05 ml w,as prepared
as for routine transplantation, and irradiated
in a flask with a single dose of90 Gy at a dose
rate of 1-28 Gy/min.
For experiments involving irradiation of
cells to be implanted in unirradiated skin,
the procedure was as for the "immunization"
experiments. but with a single dose of only
70 Gy.
Measurement of tumour size. Mice im-
planted with tumour cells were examined at
intervals of 1-2 days, and the day of definite
appearance of a palpable tumour (1-2 mm in
diameter) was recorded. Subsequent growth
wvas followed at daily intervals by measure-
ment of 3 mutually perpendicular diameters
using a specially-designed fan-shaped device
fitted with a series of slits of graded size, to
which each diameter could be compared,
correct to the nearest millimeter. An average
of 1-25 mm double skin thickness was
obtained for these mice, and this value was
subtracted from the average diameter meas-
ured for each tumour.
58GROWTH KINETICS OF TUMOURS IN X-RAYED HOSTS
Studies using minsonidazole. These experi-
inents made use of the hypoxic cell radio-
sensitizer MISO (kindly supplied by Professor
G. E. Adams) made up as a sterile solution in
0.90o 9 /v saline at a concentration of 25 mg/
ml and injected i.p. at a dose of 1 mg/g body
wrt 30 min before irradiation.
Attempted imnmunization. For these ex-
periments each mouse received 3 i.p. injec-
tions, each of 2 x 106 irradiated cells (041 ml
suspension) at weekly intervals. The mice
were challenged 3 weeks from the first injec-
tion with a tumour transplant, routinely
prepared.
EXPERIMENTS ANI) RESULTS
G(ross response and curability of tuniours
treated with large single doses ofX-rays with
and without MISO
The gross response to treatment, and
rate of cure, of C3H mammary tumours
have been described in detail elsewhere
(Abdelaal & Nias, 1979) and are sum-
marized here to provide background to the
effect of radiation on this tumour system.
These tumours showed a gross response
pattern which was clearly dose-dependent
for doses up to 50 Gy of X-rays alone
(Fig. 1), or up to 25 Gy in the case of
X-rays +MISO (Fig. 2) but was less
obviously dose-dependent thereafter, the
time-scale of complete visible regression
for tumours exposed to these higher doses
being - 3 weeks.
The tumour is not readily cured by low
doses of radiation. No cures were seen for
doses below 50 Gy for X-rays alone or
below 25 Gy for X-rays+MISO. The
curability of the tumour as a function of
X-ray dose is recorded in Table I for
X-rays alone and in Table II for X-rays +
MISO.
The biological effectiveness of the doses
used in the experiments described below
may be assessed by comparison with
Figs. I and 2, and with Tables 1 and II.
Distributions oflatentperiodfor the different
experimental categories
In these experiments, mice implanted
with 106 cells were inspected daily or near-
daily and the number of days from im-
plantation to first observation of a palp-
Mean diameter
mm
FieX. 1.-Gross tumour response to single dose of X-rays.
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Meon diameter
mm
FIG. 2.-Gross tumour response to X-rays+MISO.
TABLE I.-Curability of C3H mouse mam-
mary carcinoma by single doses ofX-rays
alone
Dose
(Gy)
< 50
60
65
70
75
>80
Curability*
(%)
0
11
33
66
82
100
* Local control at 100 days. Since very few recur-
rences occur after 100 days, this is virtually synony-
mous with cure.
A total of 199 mice were used in these experiments.
TCD5o=67 Gy.
able tumour (typically 1-2 mm in dia-
meter) which subsequently grew pro-
gressively wasrecorded for eachindividual
mouse. These observations yielded distri-
butions of latent period, the mean and
standard deviation of which are recorded
in Table III, for each of 5 experimental
categories.
Statistical comparison of the signifi-
cance of the difference of the means of
each distribution from the control dis-
tribution was carried out using the rank-
TABLE II.-Curability of C3H mouse
mammary carcinoma by single doses of
X-rays+misonidazole
Dose Curability
(Gy) (%)
<20 0
25 5-8
27-5 6-2
30 61*5
35 75
>37-5 100
A total of 199 mice were used in these experiments.
TCD5o= 31 Gy, giving an apparent dose-modifying
factor of 2-16 for MISO.
sum test (see Colquhoun, 1971) which has
the advantage that it is not necessary to
assume normality of the statistical dis-
tributions.
As may be seen from Table III neither
tumours developing from cells implanted
in previously cured sites, nor those from
cells taken from tumours recurrent after
subcurative therapy (i.e. "irradiated cells
implanted in unirradiated skin") were
significantly differentintheirmeanlatency
from routine transplants in control mice.
However, cells implanted in irradiated
skin developed significantly more slowly,
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TABLE III.-Latent periodfor different experimental categories
Category
Control
Irradiated cells implanted in unirradiated skin (70 Gy)
Unirradiated cells implanted in irradiated skin (70 Gy)
Unirradiated cells implanted in sites of previously cured
tumours (60-80 Gy X-rays only)
Unirradiated cells implanted in "Immunized" hosts
No.
mice
20
6
20
Latent Period (days)
r i _
Mean s.d.
9.3 3-48
9*2 2-47
14-4 4-66
20 8-4 3-10
20 4-85 2-25
P for
difference
ofmean
from control
>005
<0-01
>005
<0-01
Mice implanted with 106 viable cells developed tumours with 100% frequency in all categories except that
of "irradiated cells implanted in unirradiated skin". In this category, 10 mice were implanted but only 6
tumours developed.
and cells implanted in "immunized" hosts
developed significantly more rapidly, than
controls.
Rate ofgrowth oftumours in thefirst 10 days
after detection
The rates of growth of tumours in the
10 days immediately after the first
definite detection (typically at 1-2 mm in
diameter) was measured for tumours
belonging to 6 different experimental
categories. Specifically excluded from this
analysis, however, are the categories of
tumours recurrent after therapy with
X-rays alone or in combination with
MISO. The pattern and rate of growth of
recurrent tumours is considered in the
following section.
However, for the great majority of
tumours in the 6 categories considered
here, it was convenient to quantify growth
in terms of the linear increase of diameter
with time, using the method of least
squares to determine best linear slopes.
The growth curve of each tumour was
recorded, and the analysis was carried out
for each tumour individually.
An advantage of analysis of growth
curves of individual tumours is that it
facilitates the detection of the occasional
"rogue" tumour the growth pattern of
which sets it apart from the others in the
same category.
Thus, although most tumours followed
a linear pattern of increase of diameter
with time (with correlation coefficients
typically in the region of 0-95-0.99) a
small minority oftumours followed a more
erratic pattern (similar to that seen with
most of the recurrent tumours) and were
excluded from this analysis on the
arbitrary basis of a correlation coefficient
TABLE IV.-Rate of tumour growthfor 10 days after detection
Tumour group
Control
Cells implanted outside cured sites
Cells implanted at site oftumours cured with X-rays
only (60-80 Gy)
Cells implanted at site oftumours cured with X-rays
(25-50 Gy) +MISO
Cells taken from tumours recurrent after X-irradiation
(50-60 Gy) and implanted in untreated skin
Cells implanted in irradiated skin (70-Gy)
Cells implanted in "immunized" hosts
Growth rate
(mm/day)
No. , A
evaluated Mean s.d.
31 0-889 0-164
11 0-827 0-170
16 0 493 0-170
16 0 435 0-170
6
14
20
1-175 0-149
0-571 0-122
1-06 0-282
P for
difference
of mean
growth rate
from control
>005
< 0-001
< 0-001
> 0 05
< 0-001
<005
571A. S. ABDELAAL, T. E. WHELDON AND B. M. CLARKE
under 0 90. (In fact, most included
tumours had coefficients greater than 0 95
and most excluded tumours had co-
efficients less than 0.75.) The significance
ofthe excluded minority will be considered
in subsequent sections.
For the great majority of tumours in-
cluded in the analysis, the results are
shown in Table IV, from which it may be
seen that neither cells implanted beyond
cured sites, nor previously irradiated cells
taken from recurrent tumours, gave rise
to tumours whose rate of growth differed
significantly fromthoseofcontroltumours.
Cells implanted in previously cured sites
and in previously irradiated skin grew
significantly more slowly than controls.
It is of interest that cells implanted in
sites of tumours cured by X-rays alone or
by X-rays plus MISO gave rise to tumours
having rather similar growth rates, de-
spite the disparity in X-ray doses (60-80
Gy and 25-50 Gy respectively).
By complete contrast, tumours de-
veloping from cells implanted in "im-
munized" hosts grew significantly faster
than did controls.
Rate of growth of tumours in the 10 days
before animal killing
For unirradiated tumours which grew
reasonably quickly (i.e. 1 mm/day) 10
days from initial detectability at a
diameter of 1-2 mm produced tumours
with mean diameter > 10 mm, after which
it became increasingly likely that animal
killing would be required on humane
grounds.
However, for tumours which grew more
slowly, longer periods of observation were
feasible, allowing comparison ofgrowth in
the "early" and "late" phases of growth
after detection. A useful definition of such
phases is "early" for the phase 10 days
after detection and "late" for the phase
10 days before killing. For rapidly growing
tumours these phases were virtually the
same, but for slowly growing tumours they
were overlapping but not identical.
In addition, it was difficult to determine
the growth rates of recurrent tumours in
the "early" phase, which usually grew in a
highly erratic fashion, with periods of
slow growth interspersed with periods in
which transient secondary regressions
took place. The growth of these tumours,
excluded from consideration in the pre-
vious section, is most readily quantified
for the "late" phase only.
Tumour growth in the "late" phase is
tabulated in Table V. Comparison of
Tables IV and V shows that, for irradiated
tumours the growth of which was quanti-
fied in both the "early" and "late" phases,
there was a tendency for growth to
accelerate from the "early" to the "late"
phase though, in general, growth re-
mained slower than that of unirradiated
tumours.
The growth retardation of recurrent
tumours during the "early" growth phase
was not readily assessed by linear analysis,
but some idea of the magnitude of the
effect may be obtained from Table VI
which shows the mean time taken to grow
from 3 mm to 10 mm diameter for
TABLE V. Rate of tumour growthfor 10 days before killing
Growtlh rate
(mm/days)
No. Mean
Tumour group evaluated rate s.d.
31 0-889 0-164
Cells implanted in sites oftumours previously cured with
X-rays (60-80 Gy)
Cells implanted in irradiated skin (70 Gy)
Tumours recurrent after 50 Gy X-rays
Tumours recurrent after 60 Gy X-ray dose
Tumours recurrent after 65 Gy X-ray
16 0-81
14 073
8 0 79
8 0-64
7 0-71
Control
P for
difference
of mean
growth rate
from control
> 0 05
< 0-01
>005
<0-01
< 0-01
0-182
0-192
0-109
0-134
0-148
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TABLE VI.-Times for tumours to grow
from a mean diameter of 3 mm to one of
10 mm
Tumour group
Control
Tumours recurrent
after X-rays only
(>60Gy)
Tumours recurrent
after X-rays +MISO
(>25 Gy)
Cells implanted at sites
oftumours previously
cured by X-rays only
(> 60 Gy)
Cells implanted at sites
oftumours previously
cured by X-ray +
MISO (> 25 Gy)
Cells implanted in
irradiated skin (70 Gy)
No. of Mean
tumours (days)
50 8-7
S.d.
0-22
TABLE VII.-Uniformity of tumour growth
for 10 days after detection
No.
excluded
on
19 28-4 2-2 Tumour group
Control
Cells implanted in
10 24-9 3-1 sites oftumours
cured by X-rays
alone (50-80 Gy)
Cells implanted in
33 14-3 0-64 sites of tumours
cured by X-rays +
misonidazole
(25-50 Gy)
19 14-6 0-88 Cells implanted in
irradiated skin
14 13-9 0-54 (70Gy)
Cells implanted
tumours in different categories. The
striking feature of this table is the time
taken for recurrent tumours, compared to
tumours developing from cells implanted
in cured sites or in irradiated skin.
Since, as seen from Table V, the "late"
phase growth rates of these tumours were
not markedly different, the differences
seen in Table VI provide a measure ofthe
"early", non-linear growth retardation to
which recurrent tumours seemedespecially
prone.
Uniformity ofpatterns of tumour growth
As stated in the previous sections, only
in the case of the recurrent tumours did
the pattern of tumour growth conform
poorly to the model of linear increase of
diameter with time, though small numbers
of "rogue" tumours with similarly erratic
behaviour also occurred as a minority
group in some other categories.
In an attempt to quantify this pheno-
menon, Table VII shows the numbers, and
statistical significance for tumours ex-
cluded from growth-rate analysis. The
results show that such "rogue" tumours
are confined to tumours growing in sites
previously subjected to irradiation, and
that their frequency in sites ofpreviously
cured tumours is statistically significant.
outside the sites of
previously cured
tumours
Cells implanted in
"immunized" hosts
No.
tumours
31
grounds
of
nonlinear
growth
kinetics
0
P for No.
exclusions
relative
to
control
20 4 <0-05
20 4 <0 05
14 2 >0-05
11 0 -
20 0 -
Inspection of the data oIn the growth of
such tumours shows a growth rate which
is quite low, but consists of sub-phases of
active growth interrupted by phases of no
growth or even transient regression.
Taken together with the observations
on recurrent tumours, the data of Table
VII indicate that irradiation decreases the
uniformity as well as the rate of subse-
quent tumour growth. It is, however, of
interest that "rogue" tumours formed
most of the recurrent tumours (in the
"early" growth phases) but were a small
minority in other irradiated groups.
DISCUSSION AND CONCLUSIONS
The studies reported here are in broad
agreement with those of other workers.
However, we have extended the observa-
tions to a higher range of X-ray doses, to
treatments employing MISO in combina-
tion with X-rays and to the effect ofprior
"immunization" of host on the kinetics of
development and growth of mouse mam-
mary tumours.
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In addition we have monitored and
analysed thegrowth curve foreach tumour
individually, a procedure useful for the
identification of occasional "rogue"
tumours the kinetic behaviour of which
makes them untypical of their experi-
mental group.
Effect of irradiation on the latency and
average rate of tumour growth
For the great ma-jority of tumours the
uniformity of growth of which lends itself
to linear analysis, the observation of
normal latency and normal growth rates
in tumours developing from cells of
tumours recurrent after irradiation and
implanted in unirradiated skin, but ofpro-
longed latency and slower growth in
tumours developing from unirradiated
cells implanted in irradiated skin, con-
firms that normal tissue damage, rather
than residual damage to tumour cells, is
primarily responsible for the perturbation
of development and growth of tumours
irradiated in vivo. This conclusion is also
supported by the at least partial recovery
of growth rate as the tumour extends
beyond the original irradiated area.
It is of interest that the perturbation
which results from irradiation of host
tissues causes a prolonged latent period,
as well as a reduced growth rate, a finding
also reported by Urano & Suit (1971),
though not by Hewitt & Blake (1968).
This suggests that the perturbation of
growth could apply to microscopic as well
as macroscopic tumours growing in
heavily irradiated environments, though
studies with different numbers of im-
planted cells would be required to con-
firm this.
The magnitude of the effect on growth
rate during the "early" phase, an approxi-
mate halving ofthe linear rate of increase
of diameter with time for X-ray doses in
the range 60-80 Gy and, when in com-
bination with the hypoxic sensitizer
MISO for doses in the range 25-50 Gy, is
similar to that reported by Hewitt &
Blake (1968) for the dose range 10-40 Gy.
The similarity of perturbation caused
by 60-80 Gy X-rays alone or 25-50 Gy of
X-rays+MISO suggests either that nor-
mal tissues are appreciably hypoxic or
that the growth perturbation is not
markedly dependent on X-ray dose above
a threshold which is probably less than
25 Gy. The latter interpretation is con-
sistent with those of other studies (Sum-
mers et al., 1964; Urano, 1966; Hewitt &
Blake, 1968) and with our own failure to
detect a monotonic relationship between
mean growth rate and dose for recurrent
tumours.
This implies a "plateauing" ofthe effect
over a very large dose range (< 25 Gy-
> 80 Gy) a phenomenon not readily ex-
plained in terms of the radiation killing
of endothelial stem cells. If recurrent
tumours succeed in evoking a blood supply
from host tissues irradiated to doses as
high as 80 Gy, the endothelial cells respon-
sible for capillary formation must (if not
hypoxic) be extraordinarily resistant to
X-rays, or, conceivably, migrate in to the
irradiated volume from surrounding
tissues or from blood (Hewitt & Blake,
1968; Urano & Suit, 1971).
The differences between the results at
the cured and pre-irradiated sites would
suggest structural and/or functional differ-
ences at these sites. These might be the
different radiation responses ofvascularity
already existing at the time of tumour
irradiation and of non-stimulated vascu-
larity at the pre-irradiated sites.
A growth similar to that of recurrent
tumours might have been obtained at the
cured sites iffewer tumour cells (less than
106) had been used for transplantation.
This would need to be confirmed by a
dilution assay, using various concentra-
tions of tumour-cell suspension for trans-
plantation.
Recurrent tumours, and those develop-
ing at the sites of previously cured
tumours, may be able to use a pre-
existing structurally intact vascular
system (whatever the clonogenic status of
constituent cells) but cells implanted in
irradiated tissue might be expected to be
at a relative disadvantage in this case.
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This could perhaps explain the relatively
prolonged latency (Table III) of tumours
developing in irradiated tissue though,
once tumour development had taken place,
the rate of subsequent growth was not
dissimilar to that of tumours developing
in previously cured sites.
In total, these studies reinforce the con-
cept that the perturbation of tumour
growth seen after irradiation is primarily
due to normal tissue injury, particularly
of the vascular elements, and so consti-
tutes a "tumour bed effect". Thrombosis
of vessels and a general diminution of the
blood supply available to the tumour
seem plausible mechanisms for the effect
(Thomlinson & Craddock, 1967; Clifton &
Jirtle, 1975; Jirtle et al., 1978).
In this case, it is probable that not only
the rate and uniformity of growth, but
also the oxygenation status of tumours
growing in irradiated tissues, will be per-
turbed. If, as indicated here, the effect
prolongs latency also, the meaningful
interpretation of tumour regrowth delay
in terms of cell survival cannot be under-
taken without knowledge of quantitative
aspects ofthe phenomenon.
Effect of irrcadiation on uniformity of
tumour growth
The irregularity of "early" growth of
recurrent tumours, a feature long recog-
nized but seldom quantified, presents
difficulties to meaningful analysis of re-
currence and regrowth delay. Though
regrowth delays are often taken as the
time for the tumour to grow to greater than
its pre-irradiated size (in effect, to allow it
to reach the "late" growth phase), the
difficulty is not wholly avoided ifan erratic
and highly variable phase of growth con-
tributes to the recorded delay.
If non-uniformity is imposed by vascu-
lar damage to host tissues, it is not
apparent why "rogue" tumours should be
the norm for the recurrent tumours but
only a minority for other irradiated sites.
One possibility is that the diminished fre-
quency of "rogues" in the irradiated skin
and cured-site categories is a consequence
of the time of appearance (subsequent to
irradiation) of tumours in these different
groups. Thus recurrent tumours always
appeared within 100 days of irradiation,
whereas cells were implanted in irradiated
skin 100-110 days after irradiation, and
in cured sites 100-250 days after irradi-
ation.
However, there have been, to our know-
ledge, no attempts to quantitatively assess
the perturbation of uniformity of growth,
a feature no less important than rate of
growth to the understanding of in vivo
tumour responses. It is possible that,
using the form of analysis described here,
this could be done in the future.
Kinetic effects of "pre-immunization"
One of the most intriguing observations
has been the effect of "pre-immunization"
on the kinetics ofdevelopment and growth
of a subsequently transplanted tumour.
Not only did "pre-immunization" fail to
prevent transplantation or retard develop-
ment or growth, but all such transplanted
tumours developed and grew significantly
faster than the non-immunized controls.
It is difficult to say whether the effect is
immunologically mediated. Certainly, im-
munological effects cannot be excluded, in
view of the possibility of the immune
response acting as a growth-promoting
mechanism (Prehn, 1972). It is also of
interest that the presence of the tumour
seems to depress the immunocompetence
of the host, at least as measured by the
ability of host lymphocytes to respond to
the mitogen PHA in vitro an effect
abolished by cure ofthe tumour (Abdelaal
et al., 1978).
Whatever the mechanisms involved,
the results presented here provide further
evidence that, at least in some tumour
systems, inoculation with killed tumour
cells may lead to faster development and
faster subsequent growth of transplanted
tumours.
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